Showing 1 - 20 results of 39 for search 'Poole, K', query time: 0.05s
Refine Results
-
1
-
2
-
3
Parathyroid hormone - a bone anabolic and catabolic agent. by Poole, K, Reeve, J
Published 2005Journal article -
4
Yearly zoledronic acid in postmenopausal osteoporosis. by Poole, K, Kaptoge, S, Reeve, J
Published 2007Journal article -
5
Falls, fractures, and osteoporosis after stroke: time to think about protection? by Poole, K, Reeve, J, Warburton, E
Published 2002Journal article -
6
Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis. by Poole, K, Warburton, E, Reeve, J
Published 2005Journal article -
7
The effects of zoledronate on iliac bone remodelling; a histomorphometric study in stroke patients by Poole, K, Warburton, E, Loveridge, N, Reeve, J
Published 2007Conference item -
8
The effects of zoledronate on iliac bone remodelling in stroke patients by Poole, K, Loveridge, N, Vedi, S, Compston, J, Reeve, J
Published 2007Journal article -
9
A single infusion of zoledronate prevents bone loss after stroke. by Poole, K, Loveridge, N, Rose, C, Warburton, E, Reeve, J
Published 2007Journal article -
10
Zoledronate prevents bone loss after stroke by Poole, K, Warburton, E, Rose, C, Loveridge, N, Reeve, J
Published 2006Journal article -
11
Pathophysiology of bone loss after stroke; A role for vitamin D? by Poole, K, Rose, C, Loveridge, N, Warburton, E, Reeve, J
Published 2004Journal article -
12
Single dose of zoledronate prevents bone loss after acute stroke by Poole, K, Warburton, E, Rose, C, Loveridge, N, Reeve, J
Published 2006Conference item -
13
-
14
-
15
Regional thinning of cortical bone in the femoral neck in hemiplegia: A pilot study by Poole, K, Rose, C, Kaploge, S, Brown, J, Loveridge, N, Reeve, J
Published 2007Journal article -
16
A single injection of zoledronic acid may prevent bone loss after stroke: Planned interim analysis of a randomised trial by Poole, K, Rose, C, Loveridge, N, Warburton, E, Reeve, J, Grp, M
Published 2004Journal article -
17
Developing clinical performance indicators for pre‐hospital blood transfusion: The Thames Valley Air Ambulance approach by Raitt, J, Curry, N, Lewis, P, Dearman, J, Poole, K, Surendra Kumar, D
Published 2020Journal article -
18
-
19
Selerostin is a delayed secreted product of osteocytes that regulates BMU width and cortical canal infilling by Poole, K, Van Bezooijen, R, Loveridge, N, Papapoulos, SE, Lowik, C, Reeve, J
Published 2005Journal article -
20